首页> 外文期刊>Frontiers in Pharmacology >Isorhynchophylline Exerts Antinociceptive Effects on Behavioral Hyperalgesia and Allodynia in a Mouse Model of Neuropathic Pain: Evidence of a 5-HT 1A Receptor-Mediated Mechanism
【24h】

Isorhynchophylline Exerts Antinociceptive Effects on Behavioral Hyperalgesia and Allodynia in a Mouse Model of Neuropathic Pain: Evidence of a 5-HT 1A Receptor-Mediated Mechanism

机译:Isorhynchophylline对神经病疼痛小鼠模型中的行为痛觉和异常患者施加抗闭合性作用:5-HT 1a 受体介导机制的证据

获取原文
获取外文期刊封面目录资料

摘要

Chronic neuropathic pain poses a significant health problem, for which effective therapy is lacking. The current work aimed to investigate the potential antinociceptive efficacy of isorhynchophylline, an oxindole alkaloid, against neuropathic pain and elucidate mechanisms. Male C57BL/6J mice were subjected to chronic constriction injury (CCI) by loose ligation of their sciatic nerves. Following CCI surgery, the neuropathic mice developed pain-like behaviors, as shown by thermal hyperalgesia in the Hargreaves test and tactile allodynia in the von Frey test. Repetitive treatment of CCI mice with isorhynchophylline (p.o., twice per day for two weeks) ameliorated behavioral hyperalgesia and allodynia in a dose-dependent fashion (5, 15, and 45 mg/kg). The isorhynchophylline-triggered antinociception seems serotonergically dependent, since its antinociceptive actions on neuropathic hyperalgesia and allodynia were totally abolished by chemical depletion of spinal serotonin by PCPA, whereas potentiated by 5-HTP (a precursor of 5-HT). Consistently, isorhynchophylline-treated neuropathic mice showed escalated levels of spinal monoamines especially 5-HT, with depressed monoamine oxidase activity. Moreover, the isorhynchophylline-evoked antinociception was preferentially counteracted by co-administration of 5-HT _(1A) receptor antagonist WAY-100635. In vitro , isorhynchophylline (0.1-10 nM) increased the Emax (stimulation of [ ~(35)S] GTPγS binding) of 8-OH-DPAT, a 5-HT _(1A) agonist. Of notable benefit, isorhynchophylline was able to correct co-morbidly behavioral symptoms of depression and anxiety evoked by neuropathic pain. Collectively, these findings confirm, for the first time, the disease-modifying efficacy of isorhynchophylline on neuropathic hypersensitivity, and this effect is dependent on spinal serotonergic system and 5-HT _(1A) receptors.
机译:慢性神经性疼痛构成了重大的健康问题,缺乏有效的治疗。目前的作品旨在探讨异嗜酸性酸碱,氧吲哚生物碱,抗神经性疼痛和疏丁机制的潜在抗血质疗效。通过松散地结扎其坐骨神经,对雄性C57BL / 6J小鼠进行慢性收缩损伤(CCI)。在CCI手术之后,神经疗法小鼠发育出疼痛的行为,如Hargreaves在Von Frey测试中的Hargreaves试验和触觉异常的热痛觉中所示。用异嗜酸性(P.O.,每天两次两周的CCI小鼠的重复处理改善行为痛觉过敏和异常患者剂量依赖性方式(5,15和45mg / kg)。异嗜酸性触发的抗闭虫病似乎是血管正交的依赖性,因为它通过PCPA的脊髓血清素的化学耗竭完全废除了对神经性痛觉的抗痛作用,而通过5-HTP(5-HT的前体)增强。始终如一地,Isorhynchophylline治疗的神经疗法小鼠显示出升级的脊柱单胺水平,尤其是5-HT,抑制单胺氧化酶活性。此外,通过共同施用5-HT _(1A)受体拮抗剂WAY-100635,优先抵消Isorhynchophylline诱发的抗胰剂疗促。体外,异嗜酸性胰蛋白线(0.1-10nm)增加了Emax(刺激[〜(35)S]GTPγs结合)8-OH-DPAT,5-HT _(1A)激动剂。值得注意的益处,Isorhynchophylline能够纠正受神经病疼痛引起的抑郁和焦虑的共同病态行为症状。总的来说,这些发现证实了Isorhynchophyline对神经病过敏的疾病修饰的疗效,并且这种效果取决于脊柱血清正组合系统和5-HT _(1A)受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号